News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,506 Results
Type
Article (87342)
Company Profile (759)
Press Release (771380)
Multimedia
Podcasts (168)
Webinars (27)
Section
Business (233017)
Career Advice (4137)
Deals (39786)
Drug Delivery (134)
Drug Development (91229)
Employer Resources (202)
FDA (18267)
Job Trends (17394)
News (397303)
Policy (39917)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (140)
Alzheimer's disease (1669)
Antibody-drug conjugate (ADC) (217)
Approvals (18276)
Artificial intelligence (470)
Autoimmune disease (63)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (50)
Breast cancer (465)
Cancer (3709)
Cardiovascular disease (330)
Career advice (3552)
Career pathing (37)
CAR-T (237)
CDC (52)
Cell therapy (652)
Cervical cancer (32)
Clinical research (75157)
Collaboration (1336)
Company closure (4)
Compensation (898)
Complete response letters (59)
COVID-19 (2946)
CRISPR (80)
C-suite (549)
Cystic fibrosis (132)
Data (4073)
Decentralized trials (2)
Denatured (60)
Depression (107)
Diabetes (442)
Diagnostics (7075)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (178)
Drug shortages (36)
Duchenne muscular dystrophy (194)
Earnings (98694)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132618)
Executive appointments (970)
FDA (20623)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1202)
Gene editing (167)
Generative AI (45)
Gene therapy (515)
GLP-1 (1007)
Government (5370)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (36)
IgA nephropathy (55)
Immunology and inflammation (237)
Immuno-oncology (19)
Indications (51)
Infectious disease (3176)
Inflammatory bowel disease (181)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (180)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (634)
Leadership (31)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (530)
Lymphoma (256)
Machine learning (26)
Management (66)
Manufacturing (606)
MASH (129)
Medical device (14852)
Medtech (14873)
Mergers & acquisitions (22711)
Metabolic disorders (1122)
Multiple sclerosis (132)
NASH (23)
Neurodegenerative disease (212)
Neuropsychiatric disorders (59)
Neuroscience (2651)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (56)
Obesity (551)
Opinion (307)
Ovarian cancer (122)
Pain (160)
Pancreatic cancer (163)
Parkinson's disease (230)
Partnered (28)
Patents (402)
Patient recruitment (293)
Peanut (57)
People (66166)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23166)
Phase II (32638)
Phase III (24559)
Pipeline (2592)
Policy (288)
Postmarket research (3554)
Preclinical (10458)
Press Release (72)
Prostate cancer (187)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (639)
Real estate (7420)
Recruiting (78)
Regulatory (27872)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (13)
RNA editing (15)
RSV (69)
Schizophrenia (128)
Series A (198)
Series B (148)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (89)
The Weekly (106)
Vaccines (1025)
Venture capital (66)
Weight loss (385)
Women's health (57)
Worklife (21)
Date
Today (92)
Last 7 days (603)
Last 30 days (2486)
Last 365 days (33683)
2025 (25045)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50875)
Australia (8938)
California (9161)
Canada (2791)
China (862)
Colorado (389)
Connecticut (408)
Delaware (251)
Europe (116889)
Florida (1348)
Georgia (308)
Hawaii (3)
Idaho (67)
Illinois (800)
India (47)
Indiana (446)
Iowa (19)
Japan (298)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1243)
Massachusetts (6897)
Michigan (306)
Minnesota (552)
Mississippi (4)
Missouri (115)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2540)
New Mexico (32)
New York (2505)
North Carolina (1387)
North Dakota (10)
Northern California (4094)
Ohio (286)
Oklahoma (20)
Oregon (50)
Pennsylvania (1913)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3504)
Tennessee (148)
Texas (1433)
United States (33972)
Utah (272)
Virginia (242)
Washington D.C. (82)
Washington State (792)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,506 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
CSL Vifor, Bolt Cut Staff
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
October 3, 2025
·
213 min read
·
BioSpace Editorial Staff
Regulatory
Fired NIAID Director Claims Ouster Was Payback for Whistleblower Report
Jeanne Marrazzo, former director of the National Institutes of Allergy and Infectious Disease, was formally terminated Thursday after months on administrative leave, after filing a whistleblower report.
October 3, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
CMS Finalizes Stronger Protections for Orphan Drugs Against IRA Price Negotiations
Expanded exemptions for orphan drugs could mean prolonged protections for top-selling drugs like Merck’s Keytruda, which was initially approved under this designation in 2014.
October 3, 2025
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Amgen Builds Case for Repatha To Prevent Heart Disease With Late-Stage Data
Findings from the Phase III VESALIUS-CV study reinforce the cholesterol-lowering benefit of Repatha in high-risk patients without prior cardiovascular disease, for which the drug was approved in August 2024.
October 3, 2025
·
1 min read
·
Tristan Manalac
Cell and Gene Therapy
FDA’s New Cell and Gene Therapy Guidances Finally Go a ‘Click Further’ to ‘Game Changing’
Following up on previous, dimly received issuances, a new set of ideas published by the FDA to streamline regulatory pathways for cell and gene therapies ‘for small populations’ is receiving a warmer welcome—but experts warn it will take more to turn the tide for the fraught therapeutic space.
October 3, 2025
·
5 min read
·
Dan Samorodnitsky
Press Releases
Glioblastomas Affect Much More Than Just the Brain
October 3, 2025
·
6 min read
Press Releases
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel
October 3, 2025
·
2 min read
Press Releases
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
October 3, 2025
·
5 min read
Press Releases
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
October 3, 2025
·
7 min read
Press Releases
Ocugen to Present at Industry and Investor Conferences in October 2025
October 3, 2025
·
3 min read
1 of 85,951
Next
